S&P・Nasdaq 本質的価値 お問い合わせ

Revelation Biosciences, Inc. REVBW NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Revelation Biosciences, Inc. (REVBW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

アナリスト予想 一株当たり利益(EPS) $-1,436.16 および 売上高 $0.00B 来期予想.

一株当たり利益(EPS)実績推移: 2024: 実績 $-9.44 vs 予想 $-1,436.16 (上回る +99.3%). 2025: 実績 $-23.95 vs 予想 $-36.60 (上回る +34.6%). アナリスト精度: 0%.

EPS予測 — REVBW

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$9.44 vs Est –$1,436.16 ▲ 15,113.6% off
2025 Actual –$23.95 vs Est –$36.60 ▲ 52.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

売上高予測 — REVBW

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る